NCT06577675 Progression of a Group of Patients Suffering From Emotional Dysregulation But Heterogeneous in Terms of Diagnosis, Benefiting From the DBT Group Programme.
| NCT ID | NCT06577675 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Emotion Regulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2025-04-17 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2025-04-17 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Human beings experience emotions and have the ability to manage them, but when these abilities are undermined by mental illness, the result is emotional dysregulation. Borderline patients (1 to 4% of the population) suffer from this symptom and can benefit from a specific therapy: DBT (Dialectical Behaviour Therapy; Linehan, 1993). Created specifically for this condition, DBT significantly reduces emotional dysregulation, a dimension at the root of behavioural disorders that is known to be poorly relieved by drug treatments. The DBT group training programme offers patients the opportunity to learn and practise emotional regulation skills. Four types of skills are taught skills: mindfulness, interpersonal skills, emotional regulation and and distress tolerance. This therapy is part of the psychiatric care, in which patients take responsibility in their own care. There are many studies showing the effectiveness of DBT and its programme with borderline patients. But there are other pathologies concerned by emotional dysregulation: thymic disorders in particular bipolar (1 to 2.5%), addictive disorders (8 to 10%), eating disorders (ADD, 10%), post-traumatic stress disorder (PTSD, 2%).
Eligibility Criteria
Inclusion Criteria: * Patients affiliated to or entitled under a social security scheme * Patients aged 18 to 65 suffering from emotional dysregulation and presenting one of the following clinical profiles: borderline disorder, bipolar disorder, addictive disorders, eating disorders, PTSD. * Follow-up by the Saint Etienne sector (mobile teams, psychological medical centre, intra-hospital services, full-time therapeutic reception centre and day hospitals). * DERS scale score \> 94. * Patient having received informed information about the study and having signed consent to participate in the study. Exclusion Criteria: * Psychotic disorders, * Melancholic depression, * Aggressive and hostile behaviour preventing group work, * Intellectual deficit, * Patient under guardianship.
Contact & Investigator
Yohann MASSE, nurse
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT06577675 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Emotion Regulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06577675 currently recruiting?
Yes, NCT06577675 is actively recruiting participants. Contact the research team at cirps@chu-st-etienne.fr for enrollment information.
Where is the NCT06577675 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT06577675 clinical trial?
NCT06577675 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Yohann MASSE, nurse at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 32 participants.